Skip to content

Drug interactions

Efavirenz + Triclabendazole

Severity: Moderate

Efavirenz and Triclabendazole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs have been associated with QT interval prolongation, so combined use may add to arrhythmia risk, particularly in patients with other risk factors. Torsades de pointes is the concern in susceptible patients.

What this interaction means in plain words

Efavirenz and Triclabendazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Triclabendazole belongs to Anti Parasitic.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Obtain a baseline ECG and correct potassium and magnesium abnormalities before treatment. Avoid other QT-prolonging drugs and monitor ECG in patients with cardiac risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Triclabendazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Triclabendazole?

MediHelp rates the interaction as moderate. Efavirenz and Triclabendazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs have been associated with QT interval prolongation, so combined use may add to arrhythmia risk, particularly in patients with other risk factors. Torsades de pointes is the concern in susceptible patients.

How serious is the interaction between Efavirenz and Triclabendazole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium abnormalities before treatment. Avoid other QT-prolonging drugs and monitor ECG in patients with cardiac risk factors.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in